Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year

2000

Stage

Acquired | Acquired

Total Raised

$2.82M

About Cytion

Developer drug screening technology for the functional analysis of ion channel proteins. The company offers a variety of screening platforms that give direct information on the action of ion channel targeted drugs. All systems are fully automated and are distinguished by sample throughput and application area.

Cytion Headquarter Location

Ch. des Croisettes 22 CH-1066 Eplinges, Switzerland

Switzerland

41 2 16 54 70 30

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.